News

MyChesCo on MSN8h
ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer
The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® ...
Healio22h
For older adults with diabetes, personalize therapy to improve ‘health span’
The global populating is aging, and approximately 29% of people with diabetes worldwide are aged 65 years and older, ...